Opioid Use Disorder
📧 Sign up to get email alerts when something new happens for Opioid Use Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-07-07FDA Approved: SUBOXONE — Supplemental Application (INDIVIOR INC.)
FDA approved a supplemental application for Suboxone, a buprenorphine and naloxone product from Indivior Inc.
-
FDA approval · 2016-07-07FDA Approved: BUPRENORPHINE AND NALOXONE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Buprenorphine and Naloxone (Actavis Pharma, Inc.), marking the approval of a generic product.
-
CLINICAL_TRIALS trial_result · 2016-06-27Clinical Trial Update: Opioid Analgesic Use and Disposal Following Outpatient Dental Surgery [NA]
A completed clinical trial update from the University of Pennsylvania examining opioid analgesic use and disposal after outpatient dental su…
-
CLINICAL_TRIALS trial_result · 2016-06-01Clinical Trial Update: Low Dose Naltrexone-buprenorphine Transfer to Vivitrol Injection in Opioid Dependence [Phase 2]
A Phase 2 trial evaluated transitioning opioid-dependent patients from low-dose naltrexone-buprenorphine to extended-release naltrexone (Viv…
-
FDA approval · 2016-05-20FDA Approved: VIVITROL — Supplemental Application (Alkermes, Inc.)
The FDA approved a supplemental application for VIVITROL (naltrexone) by Alkermes, Inc. This action represents a supplemental approval relat…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2016-05-17Clinical Trial Update: Buccal Versus Injectable Naloxone: a Phase I Healthy Volunteer Study [Phase 1]
A Phase 1 study in healthy volunteers comparing buccal versus injectable naloxone administration.
-
CLINICAL_TRIALS trial_result · 2016-05-16Clinical Trial Update: Study to Assess Pharmacokinetic (PK), Bioavailability & Food Effect of MR902 Compared With Immediate Release (IR) Morphine Sulphate Oral Solution [Phase 1]
Phase 1 clinical trial to assess the pharmacokinetics, bioavailability, and food effect of MR902 compared with immediate-release morphine su…
-
CLINICAL_TRIALS trial_result · 2016-05-09Clinical Trial Update: Single-dose, Study of RBP-6000 in Opioid Dependent Individuals [Phase 1]
Phase 1 single-dose study of RBP-6000 for opioid use disorder has completed.
-
CLINICAL_TRIALS trial_result · 2016-05-06Clinical Trial Update: Alternate Day Buprenorphine Administration, Phase XI - 16 [Phase 2]
The document reports the completion of a Phase 2 trial evaluating alternate-day buprenorphine administration for opioid-related disorders.
-
CLINICAL_TRIALS trial_result · 2016-05-06Clinical Trial Update: Buprenorphine Detoxification With Two Types of Treatment. BBD III - 12 [Phase 2]
Phase 2 clinical trial evaluating buprenorphine detoxification using two treatment approaches for opioid use disorder; study completed.
-
CLINICAL_TRIALS trial_result · 2016-05-06Clinical Trial Update: Buprenorphine Detox With Two Types of Treatment. BBD II - 11 [Phase 2]
Phase 2 trial evaluating buprenorphine detoxification with two treatment approaches for opioid use disorder has completed.
-
CLINICAL_TRIALS trial_result · 2016-05-06Clinical Trial Update: Alternate-Day Buprenorphine Administration. Phase VIII - 9 [Phase 2]
A Phase 2 trial evaluating alternate-day buprenorphine administration for opioid use disorder has completed.
-
CLINICAL_TRIALS trial_result · 2016-05-06Clinical Trial Update: Buprenorphine Dose Alteration Study - 1 [Phase 1]
Phase 1 clinical trial evaluating dosing adjustments of buprenorphine for opioid use disorder has completed, conducted by the University of …
-
CLINICAL_TRIALS withdrawal · 2016-05-06Clinical Trial Update: Neurobiology of Opioid Dependence: 3 - 3 [Phase 2]
A Phase 2 clinical trial investigating the neurobiology of opioid dependence has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-05-06Clinical Trial Update: Neurobiology of Opioid Dependence: 4 - 4 [Phase 2]
Phase 2 clinical trial on the neurobiology of opioid dependence sponsored by Yale University has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-05-02Clinical Trial Update: Study to Evaluate the Subjective Effects of PTI-801 in Non-Physically Dependent Subjects With a History of Drug Abuse [Phase 2]
Phase 2 trial evaluating the subjective effects of PTI-801 in individuals with a history of opioid-related disorders; the study status is co…
-
CLINICAL_TRIALS research · 2016-04-28Clinical Trial Update: Observational Study to Assess the Adequacy of Methadone Dosage, in Heroin Addicted Patients in a MMT.
Completed observational study evaluating whether methadone dosages used in methadone maintenance therapy adequately address heroin addiction…
-
FDA approval · 2016-04-20FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (VistaPharm, LLC)
The FDA approved a supplemental application for methadone hydrochloride (ANDA040241) submitted by VistaPharm, LLC.
-
FDA approval · 2016-04-20FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (VistaPharm, LLC)
The FDA approved a supplemental application for methadone hydrochloride by VistaPharm, LLC, representing an approved change to an already-ap…
-
FDA approval · 2016-04-20FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Aurolife Pharma, LLC)
FDA approved Aurolife Pharma's supplemental application for methadone hydrochloride, granting approval of a generic methadone hydrochloride …
-
FDA approval · 2016-04-20FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Epic Pharma, LLC)
FDA approved a supplemental application for Methadone hydrochloride by Epic Pharma, LLC.
-
FDA approval · 2016-04-20FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (SpecGx LLC)
FDA approves a supplemental application for methadone hydrochloride manufactured by SpecGx LLC.
-
FDA approval · 2016-04-20FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Methadone Hydrochloride from Hikma Pharmaceuticals USA Inc., updating an existing generic produc…
-
FDA approval · 2016-04-15FDA Approved: SUBOXONE — Supplemental Application (INDIVIOR INC.)
FDA approved a supplemental application for SUBOXONE (buprenorphine hydrochloride and naloxone hydrochloride) submitted by Indivior.
-
CLINICAL_TRIALS trial_result · 2016-04-07Clinical Trial Update: Extended-Release Naltrexone for Opioid Relapse Prevention Following Release From Jail [Phase 3]
A Phase 3 trial evaluating extended-release naltrexone to prevent opioid relapse after release from jail has completed and posted results.